ArticlePolymers2019
PA12 Powder Recycled from SLS for FDM.
Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Review
- Continuous reuse of polyamide 12 in powder bed fusion.Scientific reports · 2025Article
- PA12 Surface Treatment and Its Effect on Compatibility with Nutritional Culture Medium to Maintain Cell Vitality and Proliferation.Bioengineering (Basel, Switzerland) · 2024Article
- Influence of the Type of Plastic and Printing Technologies on the Compressive Behavior of 3D-Printed Heel Prototypes.Materials (Basel, Switzerland) · 2023Article
- 3D printing biocompatible materials with Multi Jet Fusion for bioreactor applications.International journal of bioprinting · 2023Article
- Trilateral Multi-Functional Polyamide 12 Nanocomposites with Binary Inclusions for Medical Grade Material Extrusion 3D Printing: The Effect of Titanium Nitride in Mechanical Reinforcement and Copper/Cuprous Oxide as Antibacterial Agents.Journal of functional biomaterials · 2022Article
- Bending Strength of Polyamide-Based Composites Obtained during the Fused Filament Fabrication (FFF) Process.Materials (Basel, Switzerland) · 2022Article
- Article
- Development and Optimization of Medical-Grade Multi-Functional Polyamide 12-Cuprous Oxide Nanocomposites with Superior Mechanical and Antibacterial Properties for Cost-Effective 3D Printing.Nanomaterials (Basel, Switzerland) · 2022Article
- Recycling of Selective Laser Sintering Waste Nylon Powders into Fused Filament Fabrication Parts Reinforced with Mg Particles.Polymers · 2021Article
- Sustainable Additive Manufacturing: Mechanical Response of Polyamide 12 over Multiple Recycling Processes.Materials (Basel, Switzerland) · 2021Article
- Mode I Fracture Toughness of Polyamide and Alumide Samples obtained by Selective Laser Sintering Additive Process.Polymers · 2020Article
- Correlations between Process Parameters and Outcome Properties of Laser-Sintered Polyamide.Polymers · 2019Article
- Characterisation of Polyamide (PA)12 Nanocomposites with Montmorillonite (MMT) Filler Clay Used for the Incremental Forming of Sheets.Polymers · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, Polyamide 12 (PA12) powder recycled after selective laser sintering (SLS) was made into filaments for fused deposition modelling (FDM). Compared with fresh PA12, the melt flow rate (MFR) of the recycled PA12 powder decreased by 77%, but the mechanical properties were only slightly reduced. In FDM, the printing speed and building orientation were changed, and the performance of the printed parts was tested. If the printing speed is too fast or too slow, the mechanical properties of the parts will be affected, and there is an optimal speed range. The tensile strength, flexural modulus, and impact strength of a printed test sample made from recycled powder reached 95%, 85%, and 87% of an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.